Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig J Thomas

Showing results (161-170 of 227) with videos related to

Pageof 23
Sort By:
Breast Cancer Research and Treatment|July 30, 2018
Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagyYismeilin R Feliz-Mosquea, Ashley A Christensen, Adam S Wilson, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
A novel class of ion displacement ligands as antagonists of the αIIbβ3 receptor that limit conformational reorganization of the receptorJian-kang Jiang, Joshua G McCoy, Min Shen, et al.
Cancer Research|February 11, 2026
Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant RhabdomyosarcomaPatience Odeniyide, Alyza Skaist, Elizabeth Fenner, et al.
Molecular Cancer Therapeutics|May 5, 2022
A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath TumorsJuana Fernández-Rodríguez, Edgar Creus-Bachiller, Xiaohu Zhang, et al.
Oncogene|March 1, 2018
Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcomaTimothy McKinnon, Rosemarie Venier, Marielle Yohe, et al.
Elife|October 3, 2017
Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancerVolkan I Sayin, Sarah E LeBoeuf, Simranjit X Singh, et al.
Cell|April 9, 2016
RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient TranscriptionLaura Baranello, Damian Wojtowicz, Kairong Cui, et al.
The Journal of Clinical Investigation|March 10, 2020
Targeting AML-associated FLT3 mutations with a type I kinase inhibitorLaQuita M Jones, Katelyn Melgar, Lyndsey Bolanos, et al.
Cancer Cell|June 21, 2024
IRF4 requires ARID1A to establish plasma cell identity in multiple myelomaArnold Bolomsky, Michele Ceribelli, Sebastian Scheich, et al.
Molecular Cell|June 25, 2022
Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasisDan He, Huijin Feng, Belen Sundberg, et al.
Pageof 23

Showing results (161-170 of 227) with videos related to

Sort By:
Pageof 23
Breast Cancer Research and Treatment|July 30, 2018
Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagyYismeilin R Feliz-Mosquea, Ashley A Christensen, Adam S Wilson, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
A novel class of ion displacement ligands as antagonists of the αIIbβ3 receptor that limit conformational reorganization of the receptorJian-kang Jiang, Joshua G McCoy, Min Shen, et al.
Cancer Research|February 11, 2026
Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant RhabdomyosarcomaPatience Odeniyide, Alyza Skaist, Elizabeth Fenner, et al.
Molecular Cancer Therapeutics|May 5, 2022
A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath TumorsJuana Fernández-Rodríguez, Edgar Creus-Bachiller, Xiaohu Zhang, et al.
Oncogene|March 1, 2018
Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcomaTimothy McKinnon, Rosemarie Venier, Marielle Yohe, et al.
Elife|October 3, 2017
Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancerVolkan I Sayin, Sarah E LeBoeuf, Simranjit X Singh, et al.
Cell|April 9, 2016
RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient TranscriptionLaura Baranello, Damian Wojtowicz, Kairong Cui, et al.
The Journal of Clinical Investigation|March 10, 2020
Targeting AML-associated FLT3 mutations with a type I kinase inhibitorLaQuita M Jones, Katelyn Melgar, Lyndsey Bolanos, et al.
Cancer Cell|June 21, 2024
IRF4 requires ARID1A to establish plasma cell identity in multiple myelomaArnold Bolomsky, Michele Ceribelli, Sebastian Scheich, et al.
Molecular Cell|June 25, 2022
Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasisDan He, Huijin Feng, Belen Sundberg, et al.
Pageof 23